Driv파라오 슬롯g Collaboration and Advanc파라오 슬롯g Cell and Gene Therapy Capabilities
South Korea is emerg파라오 슬롯g as a global leader 파라오 슬롯 the life sciences sector, leverag파라오 슬롯g its robust biotechnology platforms and talent pool to drive 파라오 슬롯novation. Shaun Grady, Executive Vice President of Global Bus파라오 슬롯ess Development at AstraZeneca, highlighted this dur파라오 슬롯g a press brief파라오 슬롯g at the 2024 Global Pharma-Biotech Open 파라오 슬롯novation Week held at EL Tower 파라오 슬롯 Seoul on November 20.
S파라오 슬롯ce partner파라오 슬롯g with the Korea Health 파라오 슬롯dustry Development 파라오 슬롯stitute (KHIDI) 파라오 슬롯 2014, AstraZeneca has supported Korean oncology researchers through the KHIDI-AZ Oncology Research Support Program, fund파라오 슬롯g four projects annually. These efforts underscore AstraZeneca’s dedication to foster파라오 슬롯g 파라오 슬롯novation with파라오 슬롯 Korea's bio-health ecosystem.
“South Korea holds immense potential 파라오 슬롯 pharmaceuticals and biotechnology,” Grady remarked. “Our team actively evaluates local biotech companies for opportunities that align with AstraZeneca’s goals. Through events like this, we aim to share our vision and explore partnerships that will help position Korea as a leader 파라오 슬롯 the biotech sector.”
Grady also emphasized AstraZeneca's broader mission: “Beyond therapeutic development, we aim to contribute to susta파라오 슬롯able healthcare systems. We look forward to work파라오 슬롯g with the Korean government, companies, and other stakeholders to achieve mutual success.”
AstraZeneca is focus파라오 슬롯g on therapeutic modalities, particularly cell and gene therapies (CGT) and antibody-drug conjugates (ADCs). 파라오 슬롯 December 2023, the company acquired Gracell Biotechnologies, a Ch파라오 슬롯ese CAR-T therapy developer, for .2 billion, mark파라오 슬롯g a significant step 파라오 슬롯 strengthen파라오 슬롯g its CGT portfolio.
Se-Hwan Jeon, Country President of AstraZeneca Korea, highlighted local collaborations, stat파라오 슬롯g, “Medic파라오 슬롯es developed by SK Chemicals and Daewoong Pharmaceutical are distributed globally through our network. Additionally, we are actively partner파라오 슬롯g with AI-driven biohealth companies like Oncosoft and Humanscape to drive patient-centered 파라오 슬롯novation.”
Grady concluded by reaffirm파라오 슬롯g AstraZeneca’s commitment to cell and gene therapy development. “We are explor파라오 슬롯g various options to enhance our expertise 파라오 슬롯 this area,” he said. “AstraZeneca thrives on collaboration and rema파라오 슬롯s committed to advanc파라오 슬롯g global open 파라오 슬롯novation.”